Novo Genomics signs an MOU with Oxford Nanopore

Novo Genomics and Oxford Nanopore signed a memorandum of understanding (MOU) today, kicking off such cooperation to bring the benefits of nanopore sequencing to human health programs in the Kingdom of Saudi Arabia.

Saudi Women’s Health

Novo Genomics attended the Saudi Women’s Health Conference, where Dr.Budoor Almansour delivered a talk titled “The Role of Genomics in Women’s Health.”